Fig. 9

Bioinformatic validation of the clinical significance of ALKBH1 across multiple cancer types. The clinical significance of ALKBH1 from a pan-cancer perspective. Expression levels of ALKBH1 in various cancers and comparison between tumor and normal tissues with statistical significance denoted by asterisks (A). Kaplan–Meier survival analysis of low/high ALKBH1 expression groups in BRCA (B), ESCA (C), HNSC (D), LIHC (E), LUAD (F and UCEC (G). ***p < 0.0001, **p < 0.01, *p < 0.05 between tumor and normal